|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.999
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.998
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.997
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.996
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.996
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.995
|
Mouse |
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.995
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.994
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.994
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.992
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.990
|
Mouse |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.989
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.988
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.987
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.986
|
|
|
|
base excision repair
|
GO:0006284 |
21 |
0.986
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.985
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.983
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.982
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.980
|
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
26 |
0.980
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.979
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.979
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.977
|
Worm |
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
4 |
0.968
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.967
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.965
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.963
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.952
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.948
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.945
|
|
|
|
dna catabolic process
|
GO:0006308 |
49 |
0.945
|
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
10 |
0.945
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.944
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.942
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.939
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.938
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.936
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.936
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.920
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.916
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.914
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.913
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.909
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.906
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.904
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.904
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.901
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.901
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.900
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.900
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.900
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.897
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.892
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.890
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.889
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.882
|
Mouse |
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.881
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.880
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.878
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.875
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.871
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.868
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.865
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.863
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.853
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.853
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.848
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.841
|
|
|
|
growth
|
GO:0040007 |
202 |
0.837
|
|
|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.836
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.832
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.825
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.823
|
|
|
|
positive regulation of developmental growth
|
GO:0048639 |
16 |
0.822
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.821
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.820
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.818
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.817
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.817
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.817
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.810
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.804
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.802
|
Mouse |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.801
|
|
|
|
regulation of growth rate
|
GO:0040009 |
1 |
0.798
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.795
|
|
|
|
negative regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060633 |
3 |
0.786
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.784
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.783
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.783
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
17 |
0.780
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.778
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.777
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.774
|
|
|
|
dna recombination
|
GO:0006310 |
77 |
0.772
|
Mouse |
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.765
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.757
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.755
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.739
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.738
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.734
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.733
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.730
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.720
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.719
|
|
|
|
dna ligation
|
GO:0006266 |
10 |
0.714
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.712
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.710
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.709
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.708
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.704
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.704
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.697
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.686
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.680
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.676
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.676
|
|
|
|
gene silencing
|
GO:0016458 |
49 |
0.673
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
48 |
0.672
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.667
|
|
|
|
dna duplex unwinding
|
GO:0032508 |
30 |
0.667
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.663
|
Mouse |
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.660
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.658
|
|
|
|
protein dna complex assembly
|
GO:0065004 |
64 |
0.636
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.636
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.636
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.635
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.627
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.625
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.623
|
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.623
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.621
|
|
|
|
negative regulation of telomere maintenance
|
GO:0032205 |
9 |
0.615
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.611
|
|
|
|
non recombinational repair
|
GO:0000726 |
14 |
0.596
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.592
|
|
|
|
cellular response to peptide
|
GO:1901653 |
59 |
0.587
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.585
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.585
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.585
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
40 |
0.583
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.576
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.573
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.569
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.555
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.550
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
57 |
0.543
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.540
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.537
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.532
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.531
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.524
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.524
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.515
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.514
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.513
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.507
|
|
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.504
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.502
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.496
|
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.492
|
|
|
|
developmental growth
|
GO:0048589 |
48 |
0.491
|
|
|
|
demethylation
|
GO:0070988 |
37 |
0.485
|
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.483
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.483
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.480
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.478
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.476
|
|
|
|
regulation of multicellular organism growth
|
GO:0040014 |
8 |
0.464
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
41 |
0.461
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
3 |
0.447
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.444
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.443
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.431
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.430
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.429
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.429
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.428
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.426
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
40 |
0.423
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
63 |
0.418
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.413
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.409
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.407
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
38 |
0.403
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.402
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
54 |
0.401
|
Mouse |
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.401
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.400
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.399
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.398
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
54 |
0.392
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.391
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.390
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.386
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
59 |
0.384
|
|
|
|
nucleosome assembly
|
GO:0006334 |
50 |
0.378
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.372
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.371
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.370
|
|
|
|
telomere maintenance via telomere lengthening
|
GO:0010833 |
9 |
0.370
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.364
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.358
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.351
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.348
|
Mouse |
|
|
positive regulation of keratinocyte apoptotic process
|
GO:1902174 |
1 |
0.338
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.336
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.335
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.333
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.332
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.330
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.328
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.324
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.320
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.310
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.307
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.302
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.301
|
Mouse |
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.298
|
|
|
|
regulation of developmental growth
|
GO:0048638 |
30 |
0.297
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.293
|
|
|
|
dna demethylation
|
GO:0080111 |
12 |
0.291
|
|
|
|
autophagy
|
GO:0006914 |
88 |
0.289
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.289
|
|
|
|
nephron epithelium development
|
GO:0072009 |
23 |
0.283
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.283
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.281
|
|
|
|
multicellular organism growth
|
GO:0035264 |
8 |
0.280
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.280
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.277
|
|
|
|
positive regulation of multicellular organism growth
|
GO:0040018 |
6 |
0.275
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.272
|
|
|
|
dna ligation involved in dna repair
|
GO:0051103 |
4 |
0.268
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
65 |
0.264
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.264
|
|
|
|
telomere maintenance via telomerase
|
GO:0007004 |
8 |
0.262
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
3 |
0.255
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.254
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.253
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.253
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
41 |
0.251
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.248
|
Mouse |
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.248
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.240
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.240
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.237
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.231
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.230
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.228
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.228
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.226
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
2 |
0.223
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
47 |
0.220
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.220
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.219
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.218
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.217
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.214
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.212
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.212
|
Mouse |
|
|
dna synthesis involved in dna repair
|
GO:0000731 |
6 |
0.211
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.210
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
94 |
0.209
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.209
|
Mouse |
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.205
|
Mouse |
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.205
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.204
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.203
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.201
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.199
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.198
|
|
|
|
gonad development
|
GO:0008406 |
34 |
0.197
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.195
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.193
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.193
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.193
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.191
|
|
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.191
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.191
|
|
|
|
regulation of dna replication
|
GO:0006275 |
68 |
0.191
|
|
|
|
dna damage response detection of dna damage
|
GO:0042769 |
3 |
0.190
|
|
|
|
positive regulation of dna binding
|
GO:0043388 |
17 |
0.190
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.188
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.188
|
|
|
|
protein polymerization
|
GO:0051258 |
71 |
0.187
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.186
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.185
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.183
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.182
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.180
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
119 |
0.179
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.175
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.175
|
|
|
|
dna replication dependent nucleosome organization
|
GO:0034723 |
32 |
0.174
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.171
|
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
50 |
0.168
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.167
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.162
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.160
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.160
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.153
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.153
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
83 |
0.152
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.152
|
|
|
|
dna modification
|
GO:0006304 |
27 |
0.151
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.150
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
25 |
0.150
|
|
|
|
ventricular septum development
|
GO:0003281 |
5 |
0.150
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.148
|
|
|
|
protein adp ribosylation
|
GO:0006471 |
9 |
0.147
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.147
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.146
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.145
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.144
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
37 |
0.141
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.141
|
|
|
|
reciprocal dna recombination
|
GO:0035825 |
4 |
0.140
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
76 |
0.136
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.136
|
Mouse |
|
|
regulation of helicase activity
|
GO:0051095 |
8 |
0.136
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.133
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
64 |
0.132
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.130
|
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.130
|
|
|
|
regulation of keratinocyte apoptotic process
|
GO:1902172 |
1 |
0.128
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.127
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.126
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.125
|
|
|
|
regulation of protein polymerization
|
GO:0032271 |
63 |
0.124
|
|
|
|
telomere capping
|
GO:0016233 |
5 |
0.124
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
47 |
0.124
|
|
|
|
protein methylation
|
GO:0006479 |
74 |
0.123
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
27 |
0.123
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.123
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.122
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.122
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.121
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.120
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.118
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.118
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.118
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
41 |
0.116
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.116
|
|
|
|
negative regulation of telomere maintenance via telomerase
|
GO:0032211 |
5 |
0.116
|
|
|
|
chromatin silencing
|
GO:0006342 |
12 |
0.113
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.113
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.113
|
|
|
|
single strand break repair
|
GO:0000012 |
6 |
0.112
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.111
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.110
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.108
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.108
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.108
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
23 |
0.107
|
|
|
|
replicative cell aging
|
GO:0001302 |
3 |
0.107
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
74 |
0.105
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.104
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
32 |
0.104
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.103
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.103
|
|
|
|
telomere maintenance
|
GO:0000723 |
32 |
0.101
|
|
|
|
axonogenesis
|
GO:0007409 |
31 |
0.101
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.101
|
Mouse |
|
|
keratinocyte apoptotic process
|
GO:0097283 |
1 |
0.101
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.100
|
|
|
|
positive regulation of binding
|
GO:0051099 |
45 |
0.098
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.096
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.096
|
|
|
|
dna hypermethylation
|
GO:0044026 |
1 |
0.095
|
|
|
|
ultradian rhythm
|
GO:0007624 |
1 |
0.094
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.092
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.092
|
|
|
|
telomere organization
|
GO:0032200 |
33 |
0.091
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.090
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
18 |
0.090
|
|
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.088
|
|
|
|
gene silencing by rna
|
GO:0031047 |
26 |
0.088
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.087
|
|
|
|
smooth muscle cell differentiation
|
GO:0051145 |
8 |
0.087
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
48 |
0.086
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
26 |
0.086
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.086
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.083
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.083
|
|
|
|
nucleus organization
|
GO:0006997 |
28 |
0.082
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.082
|
|
|
|
dna strand elongation
|
GO:0022616 |
5 |
0.081
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.081
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.081
|
|
|
|
cardiac septum development
|
GO:0003279 |
13 |
0.081
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.080
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
41 |
0.080
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.079
|
|
|
|
positive regulation of telomere maintenance
|
GO:0032206 |
4 |
0.079
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.079
|
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
9 |
0.078
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.077
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.077
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.077
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.077
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.076
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.074
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.074
|
Mouse |
|
|
rna dependent dna replication
|
GO:0006278 |
16 |
0.074
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.073
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
56 |
0.073
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.071
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.071
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.070
|
|
|
|
mismatch repair
|
GO:0006298 |
15 |
0.070
|
|
|
|
atrial septum morphogenesis
|
GO:0060413 |
5 |
0.068
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.068
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.068
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.068
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.067
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
29 |
0.066
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
35 |
0.066
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
44 |
0.066
|
|
|
|
leukocyte migration
|
GO:0050900 |
107 |
0.066
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.066
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
2 |
0.065
|
|
|
|
protein glycosylation
|
GO:0006486 |
62 |
0.064
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.063
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.063
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.062
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.062
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.062
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.061
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.061
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.061
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.060
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.060
|
|
|
|
dna double strand break processing
|
GO:0000729 |
10 |
0.059
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.059
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
34 |
0.059
|
|
|
|
aging
|
GO:0007568 |
66 |
0.059
|
Worm |
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.059
|
|
|
|
nucleosome positioning
|
GO:0016584 |
3 |
0.058
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.057
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.057
|
|
|
|
glycosylation
|
GO:0070085 |
71 |
0.057
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
21 |
0.056
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.056
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
51 |
0.055
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.055
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.055
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.055
|
|
|
|
regulation of smad protein import into nucleus
|
GO:0060390 |
10 |
0.054
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
35 |
0.054
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.054
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.054
|
|
|
|
histone methylation
|
GO:0016571 |
60 |
0.054
|
|
|
|
double strand break repair via single strand annealing
|
GO:0045002 |
4 |
0.054
|
|
|
|
limb development
|
GO:0060173 |
23 |
0.054
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
4 |
0.054
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
40 |
0.053
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.053
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.053
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.053
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.052
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.051
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.051
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.051
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
43 |
0.051
|
|
|
|
multi organism metabolic process
|
GO:0044033 |
41 |
0.050
|
|
|
|
placenta development
|
GO:0001890 |
10 |
0.050
|
|
|
|
mitral valve development
|
GO:0003174 |
3 |
0.050
|
|
|
|
axon development
|
GO:0061564 |
34 |
0.050
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.050
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.049
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.049
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.048
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.048
|
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
7 |
0.047
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
47 |
0.047
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.047
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.047
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.047
|
|
|
|
microtubule polymerization or depolymerization
|
GO:0031109 |
37 |
0.046
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.046
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.046
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.046
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.045
|
|
|
|
protein localization to chromosome telomeric region
|
GO:0070198 |
6 |
0.045
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.045
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.045
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.045
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
64 |
0.044
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.044
|
|
|
|
multicellular organismal reproductive process
|
GO:0048609 |
40 |
0.043
|
|
|
|
regulation of neuron death
|
GO:1901214 |
56 |
0.043
|
|
|
|
regulation of dna repair
|
GO:0006282 |
47 |
0.043
|
|
|
|
positive regulation of cell fate commitment
|
GO:0010455 |
2 |
0.043
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
43 |
0.043
|
|
